Prostate Cancer Drugs Market Research Reports

Prostate Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Prostate Cancer Therapeutics - Global Strategic Business Report

  • Report
  • 339 Pages
From
Market Spotlight: Benign Prostatic Hyperplasia - Product Thumbnail Image

Market Spotlight: Benign Prostatic Hyperplasia

  • Report
  • 37 Pages
From
Global Prostate Cancer Testing Market 2018-2022 - Product Thumbnail Image

Global Prostate Cancer Testing Market 2018-2022

  • Report
  • 134 Pages
From
Benign Prostatic Hyperplasia Market: By Diagnosis Test, Digital Rectal Examination and Others; By Treatment Procedures; By Geography - Forecast 2018 to 2023 - Product Thumbnail Image

Benign Prostatic Hyperplasia Market: By Diagnosis Test, Digital Rectal Examination and Others; By Treatment Procedures; By Geography - Forecast 2018 to 2023

  • Report
  • 161 Pages
From
Drug Overview: Zytiga - Product Thumbnail Image

Drug Overview: Zytiga

  • Drug Pipelines
  • 21 Pages
From
Drug Overview: Xtandi - Product Thumbnail Image

Drug Overview: Xtandi

  • Drug Pipelines
  • 19 Pages
From
Drug Overview: Xofigo - Product Thumbnail Image

Drug Overview: Xofigo

  • Drug Pipelines
  • 16 Pages
From
Drug Overview: Provenge - Product Thumbnail Image

Drug Overview: Provenge

  • Drug Pipelines
  • 13 Pages
From
Drug Overview: Lupron - Product Thumbnail Image

Drug Overview: Lupron

  • Drug Pipelines
  • 9 Pages
From
Prostate Cancer Disease Coverage Forecast and Market Analysis to 2024 - Product Thumbnail Image

Prostate Cancer Disease Coverage Forecast and Market Analysis to 2024

  • Report
  • 699 Pages
From
Drug Overview: Zoladex - Product Thumbnail Image

Drug Overview: Zoladex

  • Drug Pipelines
  • 8 Pages
From
Drug Overview: Trelstar - Product Thumbnail Image

Drug Overview: Trelstar

  • Drug Pipelines
  • 8 Pages
From
Drug Overview: Firmagon - Product Thumbnail Image

Drug Overview: Firmagon

  • Drug Pipelines
  • 9 Pages
From
Drug Overview: Eligard - Product Thumbnail Image

Drug Overview: Eligard

  • Drug Pipelines
  • 9 Pages
From
Drug Overview: Yonsa - Product Thumbnail Image

Drug Overview: Yonsa

  • Drug Pipelines
  • 13 Pages
From
Drug Overview: ipatasertib - Product Thumbnail Image

Drug Overview: ipatasertib

  • Drug Pipelines
  • 16 Pages
From
Drug Overview: apalutamide - Product Thumbnail Image

Drug Overview: apalutamide

  • Drug Pipelines
  • 18 Pages
From
Drug Overview: darolutamide - Product Thumbnail Image

Drug Overview: darolutamide

  • Drug Pipelines
  • 17 Pages
From
Drug Overview: Jevtana - Product Thumbnail Image

Drug Overview: Jevtana

  • Drug Pipelines
  • 16 Pages
From
Global Prostate Cancer Partnering 2012 to 2018 - Product Thumbnail Image

Global Prostate Cancer Partnering 2012 to 2018

  • Report
  • 150 Pages
From
Loading Indicator

The second leading cause of new cancer cases in men worldwide with over two million sufferers in the US alone, prostate cancer is typically a disease that affects older men and is thus on the increase as global life expectancies continue to rise. It is also one of the largest sectors of the pharmaceutical oncology industry. Expertly formulated reports in this section will help you to formulate effective market strategies by answering key questions such as who are the main and key niche players, what are the new drugs and therapies (including vaccines and therapeutic antibodies) in the pipeline, and what are the latest areas of pharmaceutical R&D. Manufacturers will find multiple report options to assist them in assessing competition and market opportunities. Show Less Read more

adroll